Comparison efficacy of Ropivacaine versus Bupivacaine in Spinal Anesthesia in Percutaneous Nephrolithotomy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130926014779N5

Enrollment

100

Registered

2020-06-13

Start date

2019-12-31

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney stone.

Interventions

Intervention 1: Intervention group1: 15 mg of bupivacaine is administered intrathecally. Intervention 2: Intervention group2: 15 mg of ropivacaine is administered intrathecally.

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Hemodynamic stability Having the desired ASA (Classes 1 and 2 were considered the criteria for entering the study)

Exclusion criteria

Exclusion criteria: People who need medication or action other than routine care during surgery to relieve complications and reduce pain. Chronic and cancerous pains Concomitant Disorders High intracranial pressure

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Before the spinal, after the spinal and during the change of position of the patient and then every 15 minutes to the first hour and also during the entry into recovery and when leaving the recovery and finally three and six hours after the operation. Method of measurement: Visual Analogue Scale.;Nausea Vomiting. Timepoint: Before the spinal, after the spinal and during the change of position of the patient and then every 15 minutes to the first hour and also during the entry into recovery and when leaving the recovery and finally three and six hours after the operation. Method of measurement: questionnaire.;Before the spinal, after the spinal and during the change of position of the patient and then every 15 minutes to the first hour and also during the entry into recovery and when leaving the recovery and finally three and six hours after the operation. Timepoint: bromage scale. Method of measurement: bromage scale.	—

Measure

Time frame

Pain. Timepoint: Before the spinal, after the spinal and during the change of position of the patient and then every 15 minutes to the first hour and also during the entry into recovery and when leaving the recovery and finally three and six hours after the operation. Method of measurement: Visual Analogue Scale.;Nausea Vomiting. Timepoint: Before the spinal, after the spinal and during the change of position of the patient and then every 15 minutes to the first hour and also during the entry into recovery and when leaving the recovery and finally three and six hours after the operation. Method of measurement: questionnaire.;Before the spinal, after the spinal and during the change of position of the patient and then every 15 minutes to the first hour and also during the entry into recovery and when leaving the recovery and finally three and six hours after the operation. Timepoint: bromage scale. Method of measurement: bromage scale.

—

Secondary

Measure	Time frame
Hemodynamics. Timepoint: Before the spinal, after the spinal and during the change of position of the patient and then every 15 minutes to the first hour and also during the entry into recovery and when leaving the recovery and finally three and six hours after the operation. Method of measurement: Monitoring device.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactnavid kalani

Jahrom University of Medical Sciences

navidkalani@ymail.com+98 71 2536 5231

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026